As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Primary Cells Market: By Origin: Animal Primary Cells, Human Primary Cells; By Cell Type: Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Others; By End User; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Primary Cells Market Outlook

The global primary cells market attained a value of about USD 1 billion in 2020. The market is further expected to grow at a CAGR of 11.5% during the forecast period of 2022-2027 to reach nearly USD 1.9 billion by 2026.

 

The Rising Cases of Cancers are Augmenting the Market Growth of Primary Cells

The consistent growth in the global market for primary cells can be associated with the rising occurrence of cancers worldwide. Primary cells are utilised for the discovery of cancer cells and drug screening owing to effectiveness over cell lines, which is aiding the market growth. Furthermore, primary cells are further used for extensive research activities carried out for the development of relevant therapies and techniques, including cell therapies and regenerative therapies, to treat patients with cancer.

 

Global Primary Cells Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Since cancer is recognised as the leading cause of fatalities, governments and private institutes all around the world are rapidly investing in advanced healthcare technologies for effective cancer treatment, hence providing impetus to the market growth of primary cells.

 

Primary Cells: Industry Definition and Segmentation

Primary cells refer to cells taken directly from living tissues of animals or humans and are then processed to establish them for use in relevant cell therapies.

On the basis of origin, the market can be segmented into:

  • Animal Primary Cells
  • Human Primary Cells

The market, based on cell type, can be categorised into:

  • Dermatocytes
  • Gastrointestinal Cells
  • Heart Cells
  • Hematopoietic Cells
  • Hepatocytes
  • Lung Cells
  • Musculoskeletal Cells
  • Renal Cells
  • Others

Hepatocytes can be subdivided into cryopreserved hepatocytes and fresh hepatocytes.

Based on end user, the market can be divided into:

  • Life Science Research Companies
  • Research Institutes

The EMR report looks into the regional markets of primary cells like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Robust Investments into Research and Development (R&D) are Invigorating the Market Growth of Primary Cells

The global market for primary cells is being rapidly driven by robust investments into the research and development (R&D) activities for the development of effective therapies where primary cells can be used to treat several immunodeficiency disorders. Owing to the growth in biotechnology and biopharmaceutical sectors, medical researchers are constantly working on utilising primary cells from an animal or human tissue for the treatment of malignant cancers. Furthermore, the use of patient-derived specimens in innovative preclinical technologies, such as 3D cell cultures, due to their accurate outcomes, is furthering the market growth of primary cells. Moreover, the use of human primary cells is progressively becoming a preferred choice for understanding the effects of cancer cells on human body without being subjected to animal cells. This is contributing to the overall market growth of primary cells.

 

Key Industry Players in the Global Primary cells Market

The report presents a detailed analysis of the following key players in the global primary cells market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

  • Merck KGaA 
  • Axol Bioscience Ltd.
  • Cell Biologics, Inc. 
  • Lonza Group AG.
  • PromoCell GmbH 
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Origin, Cell Type, End User, Region
Breakup by Origin Animal Primary Cells, Human Primary Cells
Breakup by Cell Type Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Hepatocytes, Lung Cells, Musculoskeletal Cells, Renal Cells, Others 
Breakup by End User Life Science Research Companies, Research Institutes
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Merck KGaA, Axol Bioscience Ltd., Cell Biologics, Inc., Lonza Group AG., PromoCell GmbH, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface  
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Primary Cells Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Primary Cells Historical Market (2017-2021) 
    8.3    Global Primary Cells Market Forecast (2022-2027)
    8.4    Global Primary Cells Market by Origin
        8.4.1    Animal Primary Cells
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Human Primary Cells
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Primary Cells Market by Cell Type
        8.5.1    Dermatocytes
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Gastrointestinal Cells
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Heart Cells
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Hematopoietic Cells
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Hepatocytes
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
            8.5.5.4    Breakup by Type
                8.5.5.4.1    Cryopreserved Hepatocytes
                    8.5.5.4.1.1     Market Share
                    8.5.5.4.1.2     Historical Trend (2017-2021)
                    8.5.5.4.1.3     Forecast Trend (2022-2027)
                8.5.5.4.2    Fresh Hepatocytes
                    8.5.5.4.2.1    Market Share
                    8.5.5.4.2.2    Historical Trend (2017-2021)
                    8.5.5.4.2.3    Forecast Trend (2022-2027)
        8.5.6    Lung Cells
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Musculoskeletal Cells
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Renal Cells
            8.5.8.1    Market Share
            8.5.8.2    Historical Trend (2017-2021)
            8.5.8.3    Forecast Trend (2022-2027)
        8.5.9    Others 
    8.6    Global Primary Cells Market by End User
        8.6.1    Life Science Research Companies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Research Institutes 
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
    8.7    Global Primary Cells Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Merck KGaA 
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Axol Bioscience Ltd.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     Cell Biologics, Inc. 
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Lonza Group AG.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    PromoCell GmbH 
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Primary Cells Market: Key Industry Highlights, 2016 and 2026
2.    Global Primary Cells Historical Market: Breakup by Origin (USD Million), 2017-2021
3.    Global Primary Cells Market Forecast: Breakup by Origin (USD Million), 2022-2027
4.    Global Primary Cells Historical Market: Breakup by Cell Type (USD Million), 2017-2021
5.    Global Primary Cells Market Forecast: Breakup by Cell Type (USD Million), 2022-2027
6.    Global Primary Cells Historical Market: Breakup by End User (USD Million), 2017-2021
7.    Global Primary Cells Market Forecast: Breakup by End User (USD Million), 2022-2027
8.    Global Primary Cells Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Primary Cells Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Primary Cells Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Primary Cells Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Primary Cells Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Primary Cells Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Primary Cells Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Primary Cells Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Primary Cells Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Primary Cells Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Primary Cells Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Primary Cells Market Forecast: Breakup by Country (USD Million), 2022-2027  
20.    Global Primary Cells Market Structure

Key Questions Answered in the Report

The global primary cells market attained a value of nearly USD 1 billion in 2020.

The market is projected to grow at a CAGR of 11.5% in the forecast period of 2022-2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 1.9 billion by 2026.

The market is being primarily driven by the rising prevalence of chronic and life-threatening disorders, such as cancers.

Rising government and private investments into the healthcare sector for the development of novel techniques using primary cells for the treatment of cancer is furthering the market growth.

The major regional markets for primary cells are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The segmentations based on origin of primary cells are animal primary cells and human primary cells.

The significant cell types of primary cells include dermatocytes, gastrointestinal cells, heart cells, hematopoietic cells, hepatocytes, lung cells, musculoskeletal cells, and renal cells, among others.

The major end users of primary cells are life science research companies and research institutes.

The major players in the industry are Merck KGaA, Axol Bioscience Ltd., Cell Biologics, Inc., Lonza Group AG., and PromoCell GmbH, among others.

Analyst Review

The global primary cells market attained a value of about USD 1 billion in 2020, driven by rising prevalence of cancers. Aided by large scale investment into the healthcare sector, the market is expected to grow at a CAGR of 11.5% in the forecast period of 2022-2027 to reach nearly USD 1.9 billion by 2026.

EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. On the basis of origin, the market can be divided into animal primary cells and human primary cells. The market, based on cell type, can be broadly categorised into dermatocytes, gastrointestinal cells, heart cells, hematopoietic cells, hepatocytes, lung cells, musculoskeletal cells, and renal cells, among others. Based on end user, the market can be segmented into life science research companies and research institutes. The major regional markets for primary cells are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Merck KGaA, Axol Bioscience Ltd., Cell Biologics, Inc., Lonza Group AG., and PromoCell GmbH, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER